Qingdao Haier Biomedical Q3 2026: Flat Stock, Rising Revenue & Low‑Temp Storage Growth
Qingdao Haier Biomedical Q3 2026: flat stock, rising revenue, profit boost, & low‑temperature storage focus drives steady biotech growth.
3 minutes to read
QINGDAO HAIER BIOMEDICAL C